Helicobacter pylori therapy:Present and future

被引：9

作者：

Vincenzo De Francesco ^{[1
]}

Enzo Ierardi ^{[1
]}

Cesare Hassan ^{[2
]}

Angelo Zullo ^{[2
]}

机构：

[1] Gastroenterology Unit,Department of Medical Sciences,University of Foggia,Ospedali Riuniti,71100 Foggia,Italy

[2] Gastroenterology and Digestive Endoscopy,"Nuovo Regina Margherita" Hospital,00153 Rome,Italy

来源：

World Journal of Gastrointestinal Pharmacology and Therapeutics | 2012年 / 04期

关键词：

Helicobacter pylori; Antibiotic resistance; Virulence factors; Therapy; Eradication;

D O I：

暂无

中图分类号：

R573 [胃疾病];

学科分类号：

1002 ; 100201 ;

摘要：

Helicobacter pylori(H.pylori) plays a crucial role in the pathogenesis of chronic active gastritis,peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma,and is also involved in carcinogenesis of the stomach.H.pylori treatment still remains a challenge for physicians,since no current first-line therapy is able to cure the infection in all treated patients.Several factors may help in the eradication of therapy failure.We reviewed both bacterial and host factors involved in therapeutic management of the H.pylori infection.In addition,we evaluated data on the most successful therapy regimens-sequential and concomitant therapies-currently available for H.pylori eradication.

引用

页码：68 / 73

页数：6

共 21 条

[1]

Mechanisms of Helicobacter pylori antibiotic resistance:An updated appraisal[J]. Vincenzo De Francesco,Angelo Zullo,Cesare Hassan,Floriana Giorgio,Rosa Rosania,Enzo Ierardi.World Journal of Gastrointestinal Pathophysiology. 2011(03)

[2] Gastric cancer, Helicobacter pylori infection and other risk factors [J].

Lorenzo Fuccio ;

Leonardo Henry Eusebi ;

Franco Bazzoli .

World Journal of Gastrointestinal Oncology, 2010, (09) :342-347

[3] Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond [J].

Angelo Zullo ;

Cesare Hassan ;

Francesca Cristofari ;

Francesco Perri ;

Sergio Morini .

World Journal of Gastrointestinal Oncology, 2010, (04) :181-186

[4] Pre-treatment: urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers [J].

Yung-Chih Lai Department of Internal Medicine .

World Journal of Gastroenterology, 2004, (07) :991-994

[5] Comparative Study of Helicobacter pylori Eradication Rates of 5-Day Quadruple "Concomitant" Therapy and 7-Day Standard Triple Therapy [J].

Kim, Seung Young ;

Lee, Sang Woo ;

Kwon, Bo Sung ;

Jung, Sung Woo ;

Koo, Ja Seol ;

Yim, Hyung Joon ;

Choi, Jai Hyun .

GASTROENTEROLOGY, 2011, 140 (05) :S878-S878

[6] How to Manage Helicobacter pylori After Sequential Therapy Failure? [J].

Zullo, Angelo ;

Hassan, Cesare ;

Cristofari, Francesca ;

Iegri, Claudia ;

De Francesco, Vincenzo .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (06) :459-460

[7] Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection [J].

Wu, Deng-Chyang ;

Hsu, Ping-I ;

Wu, Jeng-Yih ;

Opekun, Antone R. ;

Kuo, Chao-Hung ;

Wu, I-Chen ;

Wang, Sophie S. W. ;

Chen, Angela ;

Hung, Wen-Chun ;

Graham, David Y. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (01) :36-41

[8] Significantly elevated Helicobacter pylori density and different genotype distribution in erosions as compared with normal gastric biopsy specimen detected by quantitative real-time PCR [J].

Molnar, Bela ;

Szoke, Dorninika ;

Ruzsovics, Agnes ;

Tulassay, Zsolt .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (04) :305-313

[9]

“Cervia II Working Group Report 2006”: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy[J] . M. Caselli,A. Zullo,G. Maconi,F. Parente,V. Alvisi,T. Casetti,D. Sorrentino,G. Gasbarrini.Digestive and Liver Disease . 2007 (8)

[10] Sequential regimens for Helicobacter pylori eradication [J].

Moayyedi, Paul .

LANCET, 2007, 370 (9592) :1010-1012

← 1 2 3 →